Insider Transactions Reported by 37 Insiders of TEVA PHARMACEUTICAL INDUSTRIES LTD

Symbol
TEVA on NYSE, TEVJF on OTC
Location
Tel Aviv

Insiders trading volume in the past year

TEVA PHARMACEUTICAL INDUSTRIES LTD executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard D. Francis President and CEO $37,072,264 -$31,051,733 -46% 05 Mar 2026
Amir Elstein Director $35,810,081 05 Jun 2025
Kare Schultz President and CEO, Director $15,013,641 01 Nov 2022
Roberto A. Mignone Director $13,888,444 -$8,464,031 -38% 16 Dec 2025
Eliyahu Sharon Kalif EVP, Chief Financial Officer $11,325,138 -$12,587,172 -53% 05 Mar 2026
Mark Sabag Executive Vice President, International Markets Commercial $9,989,061 -$12,328,059 -55% 05 Mar 2026
Sol J. Barer Director $7,255,277 05 Jun 2025
Eric A. Hughes Executive Vice President, Global R&D and Chief Medical Officer $3,411,035 -$4,080,884 -54% 05 Mar 2026
Richard Daniell EVP, Europe Commercial $2,715,723 -$11,016,289 -80% 05 Mar 2026
Christine Fox EVP, U.S. Commercial $2,688,805 -$1,999,147 -43% 05 Mar 2026
Eric Drape Executive VP Global Operations $1,972,100 05 Mar 2024
Gerald M. Lieberman Director $1,968,517 05 Jun 2025
Rosemary A. Crane Director $1,927,498 05 Jun 2025
Perry D. Nisen Director $1,792,493 05 Jun 2025
Ronit Satchi-Fainaro Director $1,666,441 05 Jun 2025
Sven Dethlefs EVP, North America Commercial $1,609,736 06 Mar 2023
Dov Bergwerk Acting Chief Legal Officer $1,272,029 28 Feb 2024
Janet S. Vergis Director $1,254,345 05 Jun 2025
Amir Weiss Chief Accounting Officer $1,068,186 -$672,068 -39% 05 Mar 2026
Tal Zvi Zaks Director $1,000,317 05 Jun 2025
Eli Shani EVP,Global Marketing&Portfolio $527,828 03 Mar 2023
Galia Inbar EVP, Chief Human Resources Officer and Corporate Affairs $447,848 03 Mar 2023
Varda Shalev Director $383,025 05 Jun 2025
Brian P. Savage Interim Chief Legal Officer $345,628 -$163,759 -32% 05 Mar 2026
Matthew Shields EVP, Global Operations $316,335 -$653,333 -67% 05 Mar 2026
David R. McAvoy EVP, Chief Legal Officer $245,652 +$20,988 +9.3% 05 Sep 2025
Placid Jover Executive Vice President, Chief Human Resources Officer $214,521 -$539,856 -72% 05 Mar 2026
Angus Grant EVP, Business Development $152,893 09 Aug 2024
Chen Lichtenstein Director $120,724 02 Dec 2025
David M. Stark Exec. VP Chief Legal Officer $28,951 06 Mar 2023
Hafrun Fridriksdottir Executive VP, Global R&D $13,496 17 May 2022
Vikki L. Conway Acting Head of Global Human Resources $0 13 May 2024
Evan Lippman EVP, Business Development 04 Mar 2026
Nechemia Jacob Peres Director 04 Aug 2022
Abbas Hussain Director 14 Jun 2021
Jean Michel Halfon Director 04 Aug 2022
Andrew Weil Chief Accounting Officer 02 Nov 2021

Recent Insider Transactions by Companies or Individuals for TEVA PHARMACEUTICAL INDUSTRIES LTD

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Mark Sabag TEVA Ordinary Shares Options Exercise 5.8% 15,723 287,042 05 Mar 2026 Direct
Mark Sabag TEVA Restricted Share Units Options Exercise -25% -15,723 47,170 05 Mar 2026 Direct
Eliyahu Sharon Kalif TEVA Ordinary Shares Options Exercise 6.52% 19,916 325,435 05 Mar 2026 Direct
Eliyahu Sharon Kalif TEVA Restricted Share Units Options Exercise -25% -19,916 59,748 05 Mar 2026 Direct
Amir Weiss TEVA Ordinary Shares Options Exercise 13% 3,537 30,695 05 Mar 2026 Direct
Amir Weiss TEVA Restricted Share Units Options Exercise -25% -3,537 10,613 05 Mar 2026 Direct
Richard D. Francis TEVA Ordinary Shares Sale -1.68% $634,160 $31.67 -20,025 1,170,639 05 Mar 2026 Direct
Richard D. Francis TEVA Ordinary Shares Options Exercise 3.7% 42,452 1,190,664 05 Mar 2026 Direct
Richard D. Francis TEVA Restricted Share Units Options Exercise -25% -42,452 127,359 05 Mar 2026 Direct
Christine Fox TEVA Ordinary Shares Sale -8.54% $250,940 $31.67 -7,924 84,905 05 Mar 2026 Direct
Christine Fox TEVA Ordinary Shares Options Exercise 23.8% 17,819 92,829 05 Mar 2026 Direct
Christine Fox TEVA Restricted Share Units Options Exercise -25% -17,819 53,459 05 Mar 2026 Direct
Eric A. Hughes TEVA Ordinary Shares Sale -8.13% $301,895 $31.67 -9,533 107,711 05 Mar 2026 Direct
Eric A. Hughes TEVA Ordinary Shares Options Exercise 20.1% 19,654 117,244 05 Mar 2026 Direct
Eric A. Hughes TEVA Restricted Share Units Options Exercise -25% -19,654 58,962 05 Mar 2026 Direct
Richard Daniell TEVA Ordinary Shares Sale -16.8% $547,705 $31.67 -17,295 85,755 05 Mar 2026 Direct
Richard Daniell TEVA Ordinary Shares Options Exercise 20.2% 17,295 103,050 05 Mar 2026 Direct
Richard Daniell TEVA Restricted Share Units Options Exercise -25% -17,295 51,887 05 Mar 2026 Direct
Placid Jover TEVA Ordinary Shares Sale -67.6% $448,108 $31.67 -14,150 6,774 05 Mar 2026 Direct
Placid Jover TEVA Ordinary Shares Options Exercise 208.9% 14,150 20,924 05 Mar 2026 Direct
Placid Jover TEVA Restricted Share Units Options Exercise -25% -14,150 42,453 05 Mar 2026 Direct
Brian P. Savage TEVA Ordinary Shares Sale -9.36% $35,690 $31.67 -1,127 10,914 05 Mar 2026 Direct
Brian P. Savage TEVA Ordinary Shares Options Exercise 42.3% 3,580 12,041 05 Mar 2026 Direct
Brian P. Savage TEVA Restricted Share Units Options Exercise -25% -3,580 10,740 05 Mar 2026 Direct
Matthew Shields TEVA Ordinary Shares Sale -63.4% $547,705 $31.67 -17,295 9,989 05 Mar 2026 Direct
Matthew Shields TEVA Ordinary Shares Options Exercise 173.1% 17,295 27,284 05 Mar 2026 Direct
Matthew Shields TEVA Restricted Share Units Options Exercise -25% -17,295 51,887 05 Mar 2026 Direct
Richard D. Francis TEVA Ordinary Shares Sale -2% $759,442 $32.46 -23,393 1,148,212 04 Mar 2026 Direct
Richard D. Francis TEVA Ordinary Shares Options Exercise 4.48% 50,223 1,171,605 04 Mar 2026 Direct
Richard D. Francis TEVA Restricted Share Units Award 136,736 136,736 04 Mar 2026 Direct
Richard D. Francis TEVA Restricted Share Units Options Exercise -33.3% -50,223 100,446 04 Mar 2026 Direct
Richard Daniell TEVA Ordinary Shares Sale -51.6% $2,983,517 $32.66 -91,345 85,755 04 Mar 2026 Direct
Richard Daniell TEVA Ordinary Shares Options Exercise 52.6% 53,973 156,639 04 Mar 2026 Direct
Richard Daniell TEVA Restricted Share Units Award 33,424 33,424 04 Mar 2026 Direct
Richard Daniell TEVA Restricted Share Units Options Exercise -100% -53,973 0 04 Mar 2026 Direct
Placid Jover TEVA Restricted Share Units Award 37,982 37,982 04 Mar 2026 Direct
Matthew Shields TEVA Restricted Share Units Award 33,424 33,424 04 Mar 2026 Direct
Mark Sabag TEVA Ordinary Shares Options Exercise 23.8% 52,113 271,319 04 Mar 2026 Direct
Mark Sabag TEVA Restricted Share Units Award 30,385 30,385 04 Mar 2026 Direct
Mark Sabag TEVA Restricted Share Units Options Exercise -100% -52,113 0 04 Mar 2026 Direct
Evan Lippman TEVA Restricted Share Units Award 27,347 27,347 04 Mar 2026 Direct
Eric A. Hughes TEVA Ordinary Shares Sale -10.4% $366,102 $32.46 -11,277 97,590 04 Mar 2026 Direct
Eric A. Hughes TEVA Ordinary Shares Options Exercise 27.2% 23,251 108,867 04 Mar 2026 Direct
Eric A. Hughes TEVA Restricted Share Units Award 50,643 50,643 04 Mar 2026 Direct
Eric A. Hughes TEVA Restricted Share Units Options Exercise -33.3% -23,251 46,503 04 Mar 2026 Direct
Eliyahu Sharon Kalif TEVA Ordinary Shares Options Exercise 22.8% 56,763 305,519 04 Mar 2026 Direct
Eliyahu Sharon Kalif TEVA Restricted Share Units Award 53,175 53,175 04 Mar 2026 Direct
Eliyahu Sharon Kalif TEVA Restricted Share Units Options Exercise -100% -56,763 0 04 Mar 2026 Direct
Christine Fox TEVA Ordinary Shares Sale -10.8% $295,362 $32.46 -9,098 75,010 04 Mar 2026 Direct
Christine Fox TEVA Ordinary Shares Options Exercise 32.2% 20,461 84,108 04 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.